Updated: Oct 16
Medically reviewed by ChinaCureLink Team
Table of Content
Why This Case Matters
Ms. Lin(alias), a liver cancer patient from Wuhan, saw her condition improve after receiving Interventional Therapy and Microwave Tumor Ablation at a licensed oncology hospital in Guangzhou, China. For international patients facing advanced liver cancer, ChinaCureLink can help arrange specialist reviews and explore access to similar interventional and minimally invasive treatment options in China.
Key Takeaways |
|
Patient Background
Ms. Lin(alias) initially noticed an abdominal mass and experienced severe loss of appetite. Medical evaluation subsequently led to a diagnosis of advanced liver cancer.
With the disease already at an advanced stage, she faced a difficult treatment situation and sought care at a licensed oncology hospital in Guangzhou, China. The treatment team carried out further assessment and developed a treatment plan tailored to her condition.
The Care Team and Approach
Her treatment was managed by a specialist team led by Professor Gao Wen (pseudonym).
The approach combined Interventional Therapy with Microwave Tumor Ablation. Interventional Therapy can deliver treatment directly toward a tumor through minimally invasive procedures, while microwave ablation uses a needle placed into the tumor under imaging guidance and applies microwave energy to generate heat within the tumor tissue.
Microwave ablation is used in the treatment of solid tumors including liver cancer. The technique can rapidly heat targeted tissue, producing coagulative necrosis within the treated area. It can also be combined with other cancer treatments according to an individual patient's condition.
For Ms. Lin(alias), the tailored treatment plan produced a rapid reduction in tumor size and a substantial fall in tumor markers.
Treatment Timeline/ Process
Before Treatment
Developed an abdominal mass and severe loss of appetite.
Underwent medical evaluation and was diagnosed with advanced liver cancer.
Faced a difficult treatment situation and sought further specialized care.
At the Hospital
Received a detailed assessment and individualized treatment plan.
Underwent Interventional Therapy to target the liver cancer.
Received Microwave Tumor Ablation as part of the treatment strategy.
Tumor size decreased rapidly following treatment.
Tumor markers fell from more than 40,000 to 522.
Advanced liver cancer treatment in China
Expressed gratitude for the medical care and support she received.
Remained determined to face the future with a positive attitude and live a better life.
Outcome
Ms. Lin's(alias) tumor markers fell dramatically from more than 40,000 to 522, alongside a rapid reduction in tumor size following Interventional Therapy and Microwave Tumor Ablation.
Her experience represents a significant treatment response. The case does not establish complete remission or a cure, and continued specialist follow-up is required to assess the longer-term status of her disease.
How ChinaCureLink Can Help International Patients to Access This Treatment
Ms. Lin's(alias) experience demonstrates how an individualized interventional treatment plan can be used for an advanced liver cancer case. International patients facing a similar diagnosis can have their medical records, imaging, and pathology reviewed by appropriate specialists in China to determine whether interventional treatment, microwave ablation, or another treatment combination may be appropriate.
ChinaCureLink helps international patients explore treatment options in China, coordinate specialist review, arrange hospital matching and scheduling, and support the practical logistics involved in traveling for cancer treatment.
Get a Second Opinion Before Fly to China
For suitable cases, ChinaCureLink can then coordinate an online consultation with the specialist to discuss the technical treatment details directly. The purpose is to help the patient understand which treatment option and which specialist center may be most appropriate before making an international treatment decision.
What Patients Say About ChinaCureLink & Medebound HEALTH
China CureLink operates under Medebound HEALTH — an internationally recognized healthcare navigation company incorporated in New York, with operations across North America and Asia-Pacific.
Rated 4.6 ⭐⭐⭐⭐⭐ at Trustpilot
Medebound HEALTH's online testimonials. Learn More
★★★★☆ Sarah Zhang · Canada· Jul 2024 · Verified “The interpreter during the video call was fantastic — super professional and answered all our questions clearly and quickly. The professor was also very patient and gave us detailed and honest guidance on our treatment options.” |
★★★★★ Andrew Goh · Singapore · Aug 2024 · Verified “My first contact with Medebound was over a year ago. Jason has always been responsive, even when I wasn't ready to proceed. When I finally did, the consultation was seamlessly arranged and the specialist was outstanding.” |
★★★★★ Daniel Wong · Singapore · Aug 2024 · Verified “I have dry eye and nothing seemed to be working, even with different medications. I heard about a medication from the U.S. that’s supposed to be really effective, but I didn’t want to try it without talking to a doctor first. MEDEBOUND connected me with a top ophthalmologist in the U.S. and it was so reassuring to get their expert advice.” |
★★★★☆ Pongsakorn · Thailand · Feb 2025 · Verified “Kiki at Medebound is amazing — so professional and helpful! They got my video consultation with an MD Anderson expert set up super fast, within just 5 working days. I am so grateful for their support.” |
Frequently Asked Questions
Can international liver cancer patients access microwave tumor ablation in China?
Yes. Microwave ablation is available as a minimally invasive treatment for selected liver cancer patients in China. Eligibility depends on tumor characteristics, overall health, previous treatment, and specialist assessment.
Can microwave ablation be combined with interventional therapy for liver cancer?
It can be combined with other cancer treatments according to an individual patient's condition. A specialist team determines whether a combined approach is appropriate after reviewing imaging, pathology, and the patient's overall clinical status.
How can an international patient get a liver cancer treatment review in China?
The process begins with a review of medical records, imaging, pathology, and previous treatment history. ChinaCureLink can help international patients arrange a specialist review and explore an appropriate treatment pathway in China.
About ChinaCureLink
ChinaCureLink helps patients across the world access the best cancer treatment at China's top hospitals, without the delays, language barriers, and administrative confusion that typically come with seeking care abroad.
We connect patients directly with China's top cancer hospitals, ensuring that from the first case submission through to treatment and follow-up, every step is guided, translated, and coordinated by a team experienced in cross-border patient care.
ChinaCureLink is proudly affiliated with Medebound HEALTH — founded by US physicians, with over 10 years of experience and more than 3,000 patients served worldwide, Medebound HEALTH is recognized by Forbes and it is one of the most trusted patient cross-border concierge service company across North America and the Asia Pacific.
Disclaimer
This account reflects one patient's individual experience, which will vary by case, diagnosis stage, and other clinical factors. ChinaCureLink facilitates access to hospitals and treatment coordination — we do not provide medical care ourselves, and this content is not medical advice. Patients and families should consult a qualified hepatologist or hepatologist-oncologist before making treatment decisions.
